recently completed beta-blocker heart attack trial in which propranolol was administered to patients following an acute myocardial infarction resulted in a 26 % decrease in total mortality and a 23 % decrease in total coronary events in the propranolol-treated patients as compared to the placebo patients during the average follow-up of 25 months .
C0027051
heart attack
C0033497
propranolol